Everi Stock Forecast, Price & News

Everi's stock was trading at $6.93 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, EVRI stock has increased by 17.2% and is now trading at $8.12.
View which stocks have been most impacted by COVID-19.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Everi in the last year. There are currently 6 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Everi.

Everi is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Everi.

Everi Holdings Inc (NYSE:EVRI) posted its quarterly earnings results on Tuesday, August, 4th. The credit services provider reported ($0.80) EPS for the quarter, missing the Zacks' consensus estimate of ($0.57) by $0.23. The credit services provider had revenue of $38.72 million for the quarter, compared to analysts' expectations of $22.04 million. Everi had a negative return on equity of 3,484.76% and a negative net margin of 17.78%.
View Everi's earnings history.

7 equities research analysts have issued 1 year target prices for Everi's stock. Their forecasts range from $8.00 to $17.00. On average, they expect Everi's share price to reach $11.14 in the next twelve months. This suggests a possible upside of 37.2% from the stock's current price.
View analysts' price targets for Everi.

Some companies that are related to Everi include Visa (V), Mastercard (MA), Fidelity National Information Servcs (FIS), Fiserv (FISV), Automatic Data Processing (ADP), Global Payments (GPN), Paychex (PAYX), FleetCor Technologies (FLT), Broadridge Financial Solutions (BR), Jack Henry & Associates (JKHY), The Western Union (WU), Genpact (G), WEX (WEX), Corelogic (CLGX) and Euronet Worldwide (EEFT).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Everi investors own include Inovio Pharmaceuticals (INO), OrganiGram (OGI), Matinas BioPharma (MTNB), Micron Technology (MU), General Electric (GE), New Residential Investment (NRZ), Advanced Micro Devices (AMD), Chesapeake Energy (CHKAQ), Dynavax Technologies (DVAX) and NVIDIA (NVDA).

Everi trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVRI."

Everi's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (6.22%), Thrivent Financial for Lutherans (4.87%), Emerald Advisers LLC (2.50%), Emerald Mutual Fund Advisers Trust (2.21%), Silvercrest Asset Management Group LLC (2.02%) and Goldman Sachs Group Inc. (1.34%). Company insiders that own Everi stock include Darren Simmons, David Lucchese, Geoffrey P Judge, Harper H Ko and Maureen T Mullarkey.
View institutional ownership trends for Everi.

EVRI stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Silvercrest Asset Management Group LLC, AQR Capital Management LLC, Marshall Wace North America L.P., Marshall Wace LLP, Balyasny Asset Management LLC, Charles Schwab Investment Management Inc., and Jacobs Levy Equity Management Inc.. Company insiders that have sold Everi company stock in the last year include Darren Simmons, and Geoffrey P Judge.
View insider buying and selling activity for Everi.

EVRI stock was acquired by a variety of institutional investors in the last quarter, including Nantahala Capital Management LLC, Granite Point Capital Management L.P., Kornitzer Capital Management Inc. KS, Emerald Advisers LLC, Emerald Mutual Fund Advisers Trust, EAM Investors LLC, Captrust Financial Advisors, and Russell Investments Group Ltd.. Company insiders that have bought Everi stock in the last two years include David Lucchese, Harper H Ko, and Maureen T Mullarkey.
View insider buying and selling activity for Everi.

Shares of EVRI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of EVRI stock can currently be purchased for approximately $8.12.

Everi has a market capitalization of $693.86 million and generates $533.23 million in revenue each year. The credit services provider earns $16.52 million in net income (profit) each year or $0.28 on an earnings per share basis. Everi employs 1,400 workers across the globe.

The official website for Everi is www.everi.com.

Everi's mailing address is 7250 S. Tenaya Way Suite 100, Las Vegas NV, 89113. The credit services provider can be reached via phone at 800-833-7110 or via email at [email protected]